The potential for big profit is driving the race to find protection against the Zika virus. Interest of big drugmakers, including Sanofi SA, GlaxoSmithKline Plc and Takeda Pharmaceuticals have been attracted by the prospect of a blockbuster vaccine against a mosquito-borne virus which has...